The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Amphivena Therapeutics
Leadership - Amphivena Therapeutics
Stock and Other Ownership Interests - Amphivena Therapeutics
Patents, Royalties, Other Intellectual Property - Amphivena Therapeutics
Travel, Accommodations, Expenses - Amphivena Therapeutics
A phase I study of AMV564 in patients with intermediate or high-risk myelodysplastic syndromes.
 
Guillermo Garcia-Manero
Honoraria - Abbvie; Acceleron Pharma; Astex Pharmaceuticals; Celgene; Helsinn Healthcare
Consulting or Advisory Role - Acceleron Pharma; Astex Pharmaceuticals; Celgene; Jazz Pharmaceuticals
Research Funding - Astex Pharmaceuticals; celgene
 
Meagan Jacoby
Honoraria - Novo Nordisk
Consulting or Advisory Role - Jazz Pharmaceuticals
Speakers' Bureau - Celgene
Research Funding - Amphivena Therapeutics; Jazz Pharmaceuticals; Sunesis Pharmaceuticals
 
David Andrew Sallman
Consulting or Advisory Role - Agios; argenx; Celyad
Speakers' Bureau - Abbvie; Agios; Celgene; Incyte; Novartis
Research Funding - Celgene
Patents, Royalties, Other Intellectual Property - Intellectual Property Patent for LB-100 in MDS
 
Tae Han
Employment - Abbvie; Amphivena Therapeutics
Stock and Other Ownership Interests - Amphivena Therapeutics; Seagen
Patents, Royalties, Other Intellectual Property - Amphivena patent (Inst); Seattle Genetics patent (Inst); Stemcentrx patent (Inst)
Travel, Accommodations, Expenses - Abbvie; Amphivena Therapeutics
 
Jeanmarie Guenot
No Relationships to Disclose
 
Eric Feldman
Employment - Amphivena Therapeutics
Leadership - Amphivena Therapeutics
Stock and Other Ownership Interests - Amphivena Therapeutics
Patents, Royalties, Other Intellectual Property - Amphivena Therapeutics
Travel, Accommodations, Expenses - Amphivena Therapeutics